Homepage
Author:
TransMedics Group, Inc.
Posted Date:
May 5, 2026
TransMedics Reports First Quarter 2026 Financial Results
TransMedics Group, Inc.
May 5, 2026
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
TransMedics Group, Inc.
April 29, 2026
TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting
TransMedics Group, Inc.
April 23, 2026
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026
TransMedics Group, Inc.
April 21, 2026
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
TransMedics Group, Inc.
February 24, 2026
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc.
February 20, 2026
TransMedics to Present at Upcoming March Investor Conferences
TransMedics Group, Inc.
February 17, 2026
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
TransMedics Group, Inc.
February 11, 2026
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
TransMedics Group, Inc.
February 9, 2026
